Irrimax Corporation is a wholly owned subsidiary of Innovation Technologies, Inc. Innovation Technologies holds the rights to US and worldwide patents that provide broad protection for the use of low concentration CHG (less than 1%) technology. Irrimax Corporation develops, manufactures and markets Irrisept Antimicrobial Wound Lavage, a single-use, manual, self-contained irrigation device comprised of 0.05% Chlorhexidine Gluconate (CHG) in 99.95% Sterile Water for Irrigation, United States Pharmacopeia (USP).

If you are a current investor and need to contact the company, please email: or call +1 770.807.3355


Print Friendly, PDF & Email